Dr. Jorge Jose Palmerola , MD
General Practice • Miami, FL
9240 Sw 72nd St, Suite 241
Miami, FL 331733261
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Jorge Palmerola is listed in NPPES under General Practice.
-
NPI assigned on September 15, 2009; this date does not establish years in practice.
-
Published CMS data list 143 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 22 prescription fills, including refills.
- Losartan Potassium — 18 prescription fills, including refills.
- Lisinopril — 15 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 10 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 85% of clinicians listed under General Practice in Miami, FL (2024, 155 clinicians with data). Median for this group: 2,748. Middle half: 534 to 8,097.
Fewer Part D prescriptions than 80% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: 2,849. Middle half: 518 to 6,924.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 46 in 2020 to 143 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
9240 Sw 72nd St
Suite 241
Miami, FL 331733261
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
266 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,556 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $41.41 across 2 records.
By nature of payment
- Food and Beverage: $41.41 across 2 records.
Reporting-company totals
- Sumitomo Pharma America, Inc.: $24.30 across 1 record.
- Eli Lilly and Company: $17.11 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2009
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 85% of clinicians listed under General Practice in Miami, FL (2024, 155 clinicians with data). Median for this group: 2,748. Middle half: 534 to 8,097.
Fewer Part D prescriptions than 80% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: 2,849. Middle half: 518 to 6,924.
Part D drug cost
A lower Part D drug cost than 85% of clinicians listed under General Practice in Miami, FL (2024, 155 clinicians with data). Median for this group: $165,864. Middle half: $21,215 to $482,159.
A lower Part D drug cost than 85% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: $166,180. Middle half: $16,824 to $452,832.
285 active clinicians are listed under General Practice with a practice address in Miami, FL (2,293 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
9.1% of these 285 clinicians have the CMS telehealth indicator.
42.8% of these 285 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 211% from 46 in 2020 to 143 in 2024.
- 2020: 46
- 2021: 233
- 2022: 437
- 2023: 214
- 2024: 143
-
30-day fills
30-day fills increased 313% from 64 in 2020 to 266 in 2024.
- 2020: 64
- 2021: 428
- 2022: 715
- 2023: 508
- 2024: 266
-
Part D drug cost
Part D drug cost went from $810 in 2020 to $1,556 in 2024.
- 2020: $810
- 2021: $2,938
- 2022: $21,021
- 2023: $1,929
- 2024: $1,556
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $149.78 in 2019 to $41.41 in 2025.
- 2019: $149.78
- 2022: $115.70
- 2023: $21.92
- 2024: $31.74
- 2025: $41.41
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $41.41.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $24.30 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $17.11 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 22 | 1,660 | $125.22 | — |
| Losartan Potassium | Losartan Potassium | 18 | 821 | $111.36 | — |
| Lisinopril | Lisinopril | 15 | 1,290 | $81.91 | — |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | 412 | $324.70 | — |
| Mupirocin | Mupirocin | 14 | 324 | $89.64 | — |
| Famotidine | Famotidine | 13 | 551 | $56.24 | — |
| Levothyroxine Sodium | Levothyroxine Sodium | 12 | 508 | $39.68 | — |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 12 | 499 | $355.76 | — |
| Atorvastatin Calcium | Atorvastatin Calcium | 11 | 990 | $78.44 | — |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 11 | 690 | $293.32 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Dentist
Doctor of Dental Medicine
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Psychiatry & Neurology - Neurology
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine - Infectious Disease
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated September 15, 2009.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Miami
- Dr. Rosa Huguet, MD
- Dr. Rafael Cartaya, MD
- Dr. Luis Vergara Villareal, MD
- Manuel Fernandez, MEDICAL DOCTOR
- Dr. Daimis Vazquez Rosabal, MD
- Dr. Juan Moises Gutierrez, MD
Mailing Address
Po Box 654051
Miami, FL 332654051
Phone: 7865141194